These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 32354239)
1. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease. Meng ZW; Baumgart DC Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):405-410. PubMed ID: 32354239 [TBL] [Abstract][Full Text] [Related]
2. Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease. Kotze PG; Spinelli A; Warusavitarne J; Di Candido F; Sahnan K; Adegbola SO; Danese S Drugs Today (Barc); 2019 Feb; 55(2):95-105. PubMed ID: 30816884 [TBL] [Abstract][Full Text] [Related]
3. INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial. Panés J; Bouma G; Ferrante M; Kucharzik T; Nachury M; de la Portilla de Juan F; Reinisch W; Selvaggi F; Tschmelitsch J; Brett NR; Ladouceur M; Binek M; Hantsbarger G; Campbell-Hill S; Karki C; Buskens C Inflamm Bowel Dis; 2022 Nov; 28(11):1737-1745. PubMed ID: 35099555 [TBL] [Abstract][Full Text] [Related]
4. Darvadstrocel: A Review in Treatment-Refractory Complex Perianal Fistulas in Crohn's Disease. Scott LJ BioDrugs; 2018 Dec; 32(6):627-634. PubMed ID: 30298387 [TBL] [Abstract][Full Text] [Related]
5. Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn's Disease: A Phase 3 Study. Furukawa S; Mizushima T; Nakaya R; Shibata M; Yamaguchi T; Watanabe K; Futami K J Crohns Colitis; 2023 Apr; 17(3):369-378. PubMed ID: 36149832 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study. Dawoud C; Widmann KM; Czipin S; Pramhas M; Scharitzer M; Stift A; Harpain F; Riss S Wien Klin Wochenschr; 2024 May; 136(9-10):289-294. PubMed ID: 37823920 [TBL] [Abstract][Full Text] [Related]
7. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S; Lancet; 2016 Sep; 388(10051):1281-90. PubMed ID: 27477896 [TBL] [Abstract][Full Text] [Related]
8. Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease. Bislenghi G; Wolthuis A; Van Assche G; Vermeire S; Ferrante M; D'Hoore A Expert Opin Biol Ther; 2019 Jul; 19(7):607-616. PubMed ID: 31121104 [No Abstract] [Full Text] [Related]
9. Mesenchymal stem cells for the treatment of complex perianal fistulas in patients with Crohn disease. Borycka-Kiciak K; Pietrzak A; Kielar M; Tarnowski W Pol Przegl Chir; 2019 Jun; 92(1):38-47. PubMed ID: 32312921 [TBL] [Abstract][Full Text] [Related]
10. A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease. Swaroop S; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Arora U; Goyal A; Kandasamy D; Sharma R; Kabilan K; Kedia S; Dash NR; Ahuja V Stem Cell Res Ther; 2024 May; 15(1):140. PubMed ID: 38745184 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell therapy for Crohn's perianal fistula-a real-world experience. White I; Yanai H; Avni I; Slavin M; Naftali T; Tovi S; Dotan I; Wasserberg N Colorectal Dis; 2024 Jan; 26(1):102-109. PubMed ID: 38095303 [TBL] [Abstract][Full Text] [Related]
12. Stem Cell Therapy for the Treatment of Crohn's Disease; Current Obstacles and Future Hopes. El-Nakeep S Curr Stem Cell Res Ther; 2022; 17(8):727-733. PubMed ID: 34514993 [TBL] [Abstract][Full Text] [Related]
13. [A new treatment option for complex perianal fistulas in Crohn's disease patients; development of darvadstrocel (allogeneic expanded adipose-derived mesenchymal stem cells) in Japan]. Yamaguchi T Nihon Yakurigaku Zasshi; 2024; 159(3):150-155. PubMed ID: 38692877 [TBL] [Abstract][Full Text] [Related]
14. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease. Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series. Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease. Castro-Poceiro J; Fernández-Clotet A; Panés J Immunotherapy; 2018 Oct; 10(14):1203-1217. PubMed ID: 30296868 [TBL] [Abstract][Full Text] [Related]
17. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease. Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018 [TBL] [Abstract][Full Text] [Related]
18. The history of Crohn's perianal fistula treatment with mesenchymal stem cells: the story of darvadstrocel. García-Olmo D; Garcia-Arranz M Expert Opin Biol Ther; 2023; 23(12):1197-1202. PubMed ID: 37992074 [TBL] [Abstract][Full Text] [Related]